Show simple item record

dc.contributor.authorDe Rycker, Manu
dc.contributor.authorHorn, David
dc.contributor.authorAldridge, Bree
dc.contributor.authorAmewu, Richard K.
dc.contributor.authorBarry, Clifton E.
dc.contributor.authorBuckner, Frederick S.
dc.contributor.authorCook, Sarah
dc.contributor.authorFerguson, Michael A. J.
dc.contributor.authorGobeau, Nathalie
dc.contributor.authorHerrmann, Jennifer
dc.contributor.authorHerrling, Paul
dc.contributor.authorHope, William
dc.contributor.authorKeiser, Jennifer
dc.contributor.authorLafuente-Monasterio, Maria Jose
dc.contributor.authorLeeson, Paul D.
dc.contributor.authorLeroy, Didier
dc.contributor.authorManjunatha, Ujjini H.
dc.contributor.authorMcCarthy, James
dc.contributor.authorMiles, Timothy J.
dc.contributor.authorMizrahi, Valerie
dc.contributor.authorMoshynets, Olena
dc.contributor.authorNiles, Jacquin
dc.contributor.authorOverington, John P.
dc.contributor.authorPottage, John
dc.contributor.authorRao, Srinivasa P. S.
dc.contributor.authorRead, Kevin D.
dc.contributor.authorRibeiro, Isabela
dc.contributor.authorSilver, Lynn L.
dc.contributor.authorSouthern, Jen
dc.contributor.authorSpangenberg, Thomas
dc.contributor.authorSundar, Shyam
dc.contributor.authorTaylor, Caitlin
dc.contributor.authorVan Voorhis, Wes
dc.contributor.authorWhite, Nicholas J.
dc.contributor.authorWyllie, Susan
dc.contributor.authorWyatt, Paul G.
dc.contributor.authorGilbert, Ian H.
dc.date.accessioned2020-06-23T20:18:16Z
dc.date.available2020-06-23T20:18:16Z
dc.date.issued2019-12
dc.date.submitted2019-09
dc.identifier.issn2373-8227
dc.identifier.issn2373-8227
dc.identifier.urihttps://hdl.handle.net/1721.1/125959
dc.description.abstractIn May 2019, the Wellcome Centre for Anti-Infectives Research (WCAIR) at the University of Dundee, UK, held an international conference with the aim of discussing some key questions around discovering new medicines for infectious diseases and a particular focus on diseases affecting Low and Middle Income Countries. There is an urgent need for new drugs to treat most infectious diseases. We were keen to see if there were lessons that we could learn across different disease areas and between the preclinical and clinical phases with the aim of exploring how we can improve and speed up the drug discovery, translational, and clinical development processes. We started with an introductory session on the current situation and then worked backward from clinical development to combination therapy, pharmacokinetic/pharmacodynamic (PK/PD) studies, drug discovery pathways, and new starting points and targets. This Viewpoint aims to capture some of the learnings.en_US
dc.language.isoen
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/acsinfecdis.9b00371en_US
dc.rightsCreative Commons Attribution 4.0 International licenseen_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_US
dc.sourceACSen_US
dc.titleSetting Our Sights on Infectious Diseasesen_US
dc.typeArticleen_US
dc.identifier.citationDe Rycker, Manu et al. "Setting Our Sights on Infectious Diseases." ACS Infectious Diseases 6, 1 (December 2019): 3–13 © 2019 American Chemical Societyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Civil and Environmental Engineeringen_US
dc.relation.journalACS Infectious Diseasesen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-03-12T18:19:37Z
dspace.date.submission2020-03-12T18:19:39Z
mit.journal.volume6en_US
mit.journal.issue1en_US
mit.licensePUBLISHER_CC
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record